Compare Palo Alto Networks Inc (PANW) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Palo Alto Networks Inc vs Repligen Corporation Common Stock — how do they compare? Palo Alto Networks Inc trades at $373.26 (market cap $324.77B), while Repligen Corporation Common Stock trades at $178.86 (market cap $11.14B). The key difference: Palo Alto Networks Inc is far larger — about 29.2× Repligen Corporation Common Stock's market cap, and Palo Alto Networks Inc is more actively traded (3,473,783 versus 1,259,263). Which is the better fit depends on your goals — on Pluang, investors hold Palo Alto Networks Inc for 82 Days and Repligen Corporation Common Stock for 0 Days on average.
| PANW | RGEN | |
|---|---|---|
Market Cap | $324.77B | $11.14B |
Volume | 3,473,783 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $419.91 | $194.57 |
52-Week Low | $141.67 | $102.87 |
Typical Hold Time | 82 Days | 0 Days |
Enterprise Value | $324.20B | $11.02B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Palo Alto Networks (PANW) trades at $375.04, down 7.13% over the past day but remains near its 52-week high. The stock shows strong technical momentum with bullish moving averages and positive sentiment from 64 buy ratings. Recent earnings beats and robust revenue growth to $9.22B in 2025 highlight fundamental strength, though valuation ratios remain elevated with a P/E of 992.58. The company's AI-driven security platform and continuous defense services are key growth drivers, positioning it well in the cybersecurity sector.
Outlook: PANW's AI integration and platformization strategy support long-term growth, with a consensus price target of $400.05 offering ~6.7% upside. Risks include premium valuation, rising costs, and competitive pressures. Investors should weigh strong fundamentals against high multiples.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
